» Articles » PMID: 24278602

A Transfer of Silver Nanoparticles from Pregnant Rat to Offspring

Overview
Journal Toxicol Res
Specialty Toxicology
Date 2013 Nov 27
PMID 24278602
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

7.9 ± 0.95 nm, dosage: 250 mg/kg) were orally administered to pregnant rats. At 4 days after parturition, four pups were randomly selected (one pup from one dam) and silver level in liver, kidney, lung and brain was determined by ICP-MS and electron microscope. As results, silver nanoparticles highly accumulated in the tissues of the pups. Silver level in the treated group was 132.4 ± 43.9 ng/g in the kidney (12.3 fold compared to control group), 37.3 ± 11.3 ng/g in the liver (7.9 fold), 42.0 ± 8.6 ng/g in the lung (5.9 fold), and 31.1 ± 4.3 ng/g in the brain (5.4 fold). This result suggested that the possible transfer of silver nanoparticles from pregnant dams to the fetus through mainly placenta.

Citing Articles

Reproductive Toxicity of Nanomaterials Using Silver Nanoparticles and as Models.

Alaraby M, Abass D, Gutierrez J, Velazquez A, Hernandez A, Marcos R Molecules. 2024; 29(23).

PMID: 39683959 PMC: 11643907. DOI: 10.3390/molecules29235802.


The adverse side effects of prenatal and postnatal rats' exposure to silver nanoparticles Induced toxicity.

Al-Haid S, Elalfy M, Alsyaed E, Abouelmagd M, Al-Jazzar A, Al-Hizab F Open Vet J. 2024; 14(8):1999-2006.

PMID: 39308729 PMC: 11415893. DOI: 10.5455/OVJ.2024.v14.i8.29.


Safety and Toxicity Implications of Multifunctional Drug Delivery Nanocarriers on Reproductive Systems and .

Ahmad A Front Toxicol. 2022; 4:895667.

PMID: 35785262 PMC: 9240477. DOI: 10.3389/ftox.2022.895667.


Low Concentrations of Silver Nanoparticles Inhibit Spore Germination and Disturb Gender Differentiation of (L.) Brongn.

Lu Z, Yin L, Li W, Jiang H Nanomaterials (Basel). 2022; 12(10).

PMID: 35630950 PMC: 9143685. DOI: 10.3390/nano12101730.


Developmental exposure to silver nanoparticles leads to long term gut dysbiosis and neurobehavioral alterations.

Lyu Z, Ghoshdastidar S, Rekha K, Suresh D, Mao J, Bivens N Sci Rep. 2021; 11(1):6558.

PMID: 33753813 PMC: 7985313. DOI: 10.1038/s41598-021-85919-7.


References
1.
Park K, Park E, Chun I, Choi K, Lee S, Yoon J . Bioavailability and toxicokinetics of citrate-coated silver nanoparticles in rats. Arch Pharm Res. 2011; 34(1):153-8. DOI: 10.1007/s12272-011-0118-z. View

2.
Benn T, Cavanagh B, Hristovski K, Posner J, Westerhoff P . The release of nanosilver from consumer products used in the home. J Environ Qual. 2011; 39(6):1875-82. PMC: 4773917. DOI: 10.2134/jeq2009.0363. View

3.
Kulvietis V, Zalgeviciene V, Didziapetriene J, Rotomskis R . Transport of nanoparticles through the placental barrier. Tohoku J Exp Med. 2011; 225(4):225-34. DOI: 10.1620/tjem.225.225. View

4.
Kim Y, Kim J, Cho H, Rha D, Kim J, Park J . Twenty-eight-day oral toxicity, genotoxicity, and gender-related tissue distribution of silver nanoparticles in Sprague-Dawley rats. Inhal Toxicol. 2008; 20(6):575-83. DOI: 10.1080/08958370701874663. View

5.
Tang J, Xiong L, Wang S, Wang J, Liu L, Li J . Distribution, translocation and accumulation of silver nanoparticles in rats. J Nanosci Nanotechnol. 2009; 9(8):4924-32. DOI: 10.1166/jnn.2009.1269. View